1. Home
  2. CYCN vs CHEK Comparison

CYCN vs CHEK Comparison

Compare CYCN & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • CHEK
  • Stock Information
  • Founded
  • CYCN 2018
  • CHEK 2004
  • Country
  • CYCN United States
  • CHEK Israel
  • Employees
  • CYCN N/A
  • CHEK N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • CHEK Medical Electronics
  • Sector
  • CYCN Health Care
  • CHEK Health Care
  • Exchange
  • CYCN Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • CYCN 8.4M
  • CHEK 9.0M
  • IPO Year
  • CYCN N/A
  • CHEK 2015
  • Fundamental
  • Price
  • CYCN $2.88
  • CHEK $0.80
  • Analyst Decision
  • CYCN
  • CHEK
  • Analyst Count
  • CYCN 0
  • CHEK 0
  • Target Price
  • CYCN N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • CYCN 5.8M
  • CHEK 71.8K
  • Earning Date
  • CYCN 03-04-2025
  • CHEK 03-04-2025
  • Dividend Yield
  • CYCN N/A
  • CHEK N/A
  • EPS Growth
  • CYCN N/A
  • CHEK N/A
  • EPS
  • CYCN N/A
  • CHEK N/A
  • Revenue
  • CYCN $194,000.00
  • CHEK N/A
  • Revenue This Year
  • CYCN N/A
  • CHEK N/A
  • Revenue Next Year
  • CYCN N/A
  • CHEK N/A
  • P/E Ratio
  • CYCN N/A
  • CHEK N/A
  • Revenue Growth
  • CYCN N/A
  • CHEK N/A
  • 52 Week Low
  • CYCN $1.27
  • CHEK $0.56
  • 52 Week High
  • CYCN $9.47
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 44.13
  • CHEK 39.16
  • Support Level
  • CYCN $2.89
  • CHEK $0.81
  • Resistance Level
  • CYCN $4.80
  • CHEK $0.92
  • Average True Range (ATR)
  • CYCN 0.75
  • CHEK 0.09
  • MACD
  • CYCN -0.11
  • CHEK -0.01
  • Stochastic Oscillator
  • CYCN 14.68
  • CHEK 0.00

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: